300016.SZ
Beijing Beilu Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 9.74
−6.70%Aug 31, 2026, 09:27 UTC
Beijing Beilu Pharmaceutical's deputy general manager Zong Li completed a share reduction plan, selling 30,600 shares via centralized bidding from July 14 to August 28, 2026, at an average price of 9.05 yuan per share.
Source:Aug 24, 2026, 08:36 UTC
Beijing Beilu Pharmaceutical announced its H1 2026 results: revenue of 673 million yuan, up 15.26% year-on-year; net profit attributable to shareholders of 79.7521 million yuan, up 166.13% year-on-year.
Source:Aug 24, 2026, 08:36 UTC
Beijing Beilu Pharmaceutical announced a cash dividend of 0.6 yuan per 10 shares (tax included) based on 582 million shares, with no bonus shares or capital reserve conversion.
Source: